Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

The microRNA-m6A epitranscriptome: Integrative analysis of its role in normal brain behaviour and the development of epilepsy

Descrizione del progetto

Il ruolo della metilazione dei microRNA nell’epilessia

L’epilessia è un disturbo neurologico caratterizzato da convulsioni innescate da un’attività neurale anomala nel cervello. La ricerca nel corso degli anni ha fornito preziose informazioni sul meccanismo molecolare alla base dell’epilettogenesi. Il progetto MethylMiR, finanziato dall’UE, si concentra sui microRNA (miRNA), brevi molecole di RNA a singolo filamento note per il loro ruolo nella regolazione trascrizionale e post-trascrizionale dell’espressione genica. I ricercatori desiderano comprendere in quale modo la metilazione dei miRNA possa influenzare l’attività neurale cerebrale. Essi valuteranno i miRNA metilati nell’ippocampo nel cervello nell’epilessia e testeranno anche la possibilità di prendere di mira la metilazione dei miRNA come intervento terapeutico in un modello murino di malattia.

Obiettivo

Evidence is emerging that persistent changes in gene expression regulation and post-transcriptional regulation underlies the epileptogenic process. The current proposal builds on preliminary data which suggests that microRNAs (miRNA), which have recently emerged as critical regulators of epileptogenesis, may be subjected to adenosine methylation (m6A), and that this process may also be disrupted in epilepsy, representing an unexplored layer of gene expression regulation likely to influence neuronal activity and seizures. The current proposal will evaluate the effect of m6A on miRNA function, to understand how this influences normal brain behaviour and epileptogenesis. To achieve this, a combined strategy will be used, including interdisciplinary approaches, international and national secondments (University of Aarhus and RSCI), and intersectoral collaborations, which encompasses clinicians (Beaumont Hospital) and industry (STORM Therapeutics). First, hippocampal m6A-tagged miRNAs both during epileptogenesis and in chronic epilepsy will be profiled using an adapted m6A-seq approach using an epilepsy mouse model and resected human epilepsy brain tissue. Then, the effect of m6A on miRNA function and neuronal integrity will be evaluated by targeting miRNA methylation in both mouse and human cell lines. Next, clinical outcomes of pharmacological targeting of miRNA methylation on epilepsy development will be evaluated using an epilepsy mouse model. Together this proposal represents the first miRNA methylation study in the brain, which is hoped will illuminate novel therapeutic strategies for the treatment of epilepsy. This project is ideal to further my interest in translational neuroscience while also developing a network of collaborators across Europe and develop my scientific skills. This fellowship represents the best option to achieve my career goal of establishing myself as an independent researcher and consolidating my career in the European research environment.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2021-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Contributo netto dell'UE
€ 246 180,47
Indirizzo
BELFIELD
4 Dublin
Irlanda
Regione
Ireland Eastern and Midland Dublin
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Partner (2)